Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
52.65
+0.86 (1.66%)
At close: Jul 1, 2026
SHE:301033 Market Cap
SHE:301033 has a market cap or net worth of 3.51 billion as of July 1, 2026. Its market cap has decreased by -17.29% in one year.
Market Cap
3.51B
Enterprise Value
3.22B
Revenue
373.49M
Ranking
n/a
PE Ratio
32.10
Stock Price
52.65
Market Cap Chart
Since July 26, 2021, SHE:301033's market cap has decreased from 4.69B to 3.51B, a decrease of -25.16%. That is a compound annual growth rate of -5.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 3.51B | -22.00% |
| Dec 31, 2025 | 4.50B | 61.81% |
| Dec 31, 2024 | 2.78B | -3.27% |
| Dec 29, 2023 | 2.88B | 18.06% |
| Dec 30, 2022 | 2.44B | -39.66% |
| Dec 31, 2021 | 4.04B | -13.95% |
| Jul 26, 2021 | 4.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contec Medical Systems Co.,Ltd | 4.14B |
| Shenzhen Lifotronic Technology | 4.11B |
| CareRay Digital Medical Technology | 4.08B |
| Guangdong Biolight Meditech | 4.06B |
| Hangzhou AGS MedTech | 4.04B |
| Shanghai Aohua Photoelectricity Endoscope | 3.82B |
| Getein Biotech | 3.81B |
| GKHT Medical Technology | 3.80B |